Monument Therapeutics

Monument TX is an independent biotechnology company headquartered in the UK, primarily focused on developing a new drug for severe diseases of the central nervous system. The company's medical approach utilizes proprietary digital biomarkers to reduce heterogeneity and identify patients with homogeneous underlying neurobiology, enabling researchers to concentrate on advancements in neuroscience drugs within areas of unmet medical need.